|
市場調査レポート
商品コード
1672650
アドバンスドDDS（ドラッグデリバリーシステム）市場：タイプ別、用途別、キャリアタイプ別、エンドユーザー別、地域別Advanced Drug Delivery Systems Market, By Type, By Application, By Carrier Type, By End User, By Geography |
||||||
カスタマイズ可能
|
|||||||
| アドバンスドDDS（ドラッグデリバリーシステム）市場：タイプ別、用途別、キャリアタイプ別、エンドユーザー別、地域別 |
|
出版日: 2025年02月10日
発行: Coherent Market Insights
ページ情報: 英文 172 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
世界のアドバンスドDDS（ドラッグデリバリーシステム）市場は、2025年には2,694億8,000万米ドルと推定され、2032年には4,027億9,000万米ドルに達すると予測され、2025年から2032年にかけてCAGR5.9％で成長すると予測されています。
| レポート範囲 | レポート詳細 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025年の市場規模 | 2,694億8,000万米ドル |
| 実績データ | 2020年から2024年まで | 予測期間 | 2025年から2032年 |
| 予測期間：2025年～2032年 CAGR： | 5.90% | 2032年の価値予測 | 4,027億9,000万米ドル |
アドバンスドDDSは、局所治療や持続的治療のために薬物を体内の部位に特異的にターゲティングできる新規製剤の開発を可能にしました。ナノテクノロジーやその他の工学的アプローチにより、ミセル、デンドリマー、リポソーム、ポリマーナノ粒子など、薬物を分解から保護し、放出を制御できるインテリジェントなデリバリー・ビークルの創出が容易になりました。このようなデリバリー・プラットフォームは、薬剤の有効性を高め、望ましくない副作用を減らすことで、多くの薬剤の治療指数を改善するのに役立っています。生物学的障壁を越えて治療ペイロードを正確に送達する能力を持つアドバンスドDDSは、がんやその他の深刻な疾患の治療に革命をもたらしています。
市場力学：
アドバンスドDDS市場は、標的を定めて制御されたドラッグデリバリーに対する需要の高まりによって牽引されています。革新的な製剤を開発するための製薬企業による研究開発投資の増加と、がんなどの慢性疾患の有病率の上昇が、市場の成長を後押ししています。しかし、高い開発コストと規制上の問題が新規参入企業の課題となっています。新興国の未開拓の潜在力は市場拡大の好機となります。さらに、長時間作用型注射剤のような先進デリバリー技術の応用範囲の拡大は、医薬品開発者にとって新たな道を開く可能性があります。
本調査の主な特徴
本レポートでは、世界のアドバンスドDDS市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模および複合年間成長率（CAGR%）を掲載しています。
また、さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案のマトリックスについて説明しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。
世界のアドバンスドDDS市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいて掲載しています。
主要企業には、バクスター、3M、アボット、Datwyler Holding Inc.、エボニック、アストラゼネカ、Novo Nordisk A/S、Corium Innovations, Inc.、PolyActiva、Teleflex Incorporated、Elixir Medical、B. Braun SE、Nemera、Epion Therapeutics, Inc.、テルモ、Flowonix Medical Inc.などがあります。
このレポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
この調査レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者を対象としています。
利害関係者は、世界のアドバンスドDDS市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。
目次
第1章 調査の目的と前提条件
- 調査目的
- 前提条件
- 略語
第2章 市場の展望
- レポートの説明
- 市場の定義と範囲
- エグゼクティブサマリー
第3章 市場力学、規制、動向の分析
- 市場力学
- 影響分析
- 主なハイライト
- 規制シナリオ
- 製品の発売/承認
- PEST分析
- PORTERの分析
- 合併と買収のシナリオ
- 疫学
第4章 アドバンスドDDS市場、タイプ別、2020年-2032年、（10億米ドル）
- 経口ドラッグデリバリーシステム
- 注射ドラッグデリバリーシステム
- 吸入/肺ドラッグデリバリーシステム
- 経皮ドラッグデリバリーシステム
- キャリアベースのドラッグデリバリーシステム
- その他（経粘膜ドラッグデリバリーシステム等）
第5章 アドバンスドDDS市場、用途別、2020年-2032年、（10億米ドル）
- 心血管疾患
- 腫瘍学
- 泌尿器科
- 眼科
- 炎症性疾患
- その他（感染症等）
第6章 アドバンスドDDS市場、キャリアタイプ別、2020年-2032年、（10億米ドル）
- リポソーム
- ナノ粒子
- マイクロスフィア
- モノクローナル抗体
第7章 アドバンスドDDS市場、エンドユーザー別、2020年-2032年、（10億米ドル）
- 病院
- 専門クリニック
- その他（研究機関等）
第8章 世界のアドバンスドDDS市場、地域別、2020年-2032年、金額（10億米ドル）
- 北米
- ラテンアメリカ
- 欧州
- アジア太平洋
- 中東
- アフリカ
第9章 競合情勢
- Baxter
- 3M
- Abbott
- Datwyler Holding Inc.
- Evonik
- Astrazeneca
- Novo Nordisk A/S
- Corium Innovations, Inc.
- PolyActiva
- Teleflex Incorporated
- Elixir Medical
- Braun SE
- Nemera
- Epion Therapeutics, Inc.
- Terumo Corporation
- Flowonix Medical Inc
第10章 アナリストの推奨事項
第11章 参考文献と調査手法
- 参考文献
- 調査手法
- 出版社について
Global Advanced Drug Delivery Systems Market is estimated to be valued at USD 269.48 Bn in 2025 and is expected to reach USD 402.79 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 269.48 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 5.90% | 2032 Value Projection: | USD 402.79 Bn |
Advanced drug delivery systems have enabled the development of novel formulations that can specifically target drugs to areas of the body for localized or sustained treatment. Nanotechnology and other engineering approaches have facilitated the creation of intelligent delivery vehicles like micelles, dendrimers, liposomes, and polymeric nanoparticles that can shield drugs from degradation and control their release. Such delivery platforms help improve the therapeutic index of many drugs by increasing their efficacy and reducing unwanted side effects. With their ability to cross biological barriers and precisely deliver therapeutic payloads, advanced drug delivery systems are revolutionizing the treatment of cancer and other serious diseases.
Market Dynamics:
The advanced drug delivery systems market is driven by the growing demand for targeted and controlled drug delivery. Increasing R&D investments by pharmaceutical companies to develop innovative formulations and the rising prevalence of chronic diseases like cancer are fueling market growth. However, high development costs and regulatory issues pose challenges to new entrants. The untapped potential of emerging economies presents an opportunity for market expansion. Additionally, the growing application scope of advanced delivery technologies like long-acting injectables could open new avenues for drug developers.
Key features of the study:
This report provides in-depth analysis of the global advanced drug delivery systems market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global advanced drug delivery systems market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Baxter, 3M, Abbott, Datwyler Holding Inc., Evonik, Astrazeneca, Novo Nordisk A/S, Corium Innovations, Inc., PolyActiva, Teleflex Incorporated, Elixir Medical, B. Braun SE, Nemera, Epion Therapeutics, Inc., Terumo Corporation, and Flowonix Medical Inc
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global advanced drug delivery systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global advanced drug delivery systems market
Market Segmentation
- Type Insights
- Oral Drug Delivery System
- Injection-Based Drug Delivery System
- Inhalation/Pulmonary Drug Delivery System
- Transdermal Drug Delivery System
- Carrier Based Drug Delivery System
- Others (Transmucosal Drug Delivery System, etc.)
- Application Insights
- Cardiovascular Diseases
- Oncology
- Urology
- Ophthalmology
- Inflammatory Diseases
- Others (Infectious Diseases, etc.)
- Carrier Type Insights
- Liposomes
- Nanoparticles
- Microspheres
- Monoclonal Antibodies
- End User Insights
- Hospitals
- Specialty Clinics
- Others (Research Institutes, etc.)
- Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Baxter
- 3M
- Abbott
- Datwyler Holding Inc.
- Evonik
- Astrazeneca
- Novo Nordisk A/S
- Corium Innovations, Inc.
- PolyActiva
- Teleflex Incorporated
- Elixir Medical
- Braun SE
- Nemera
- Epion Therapeutics, Inc.
- Terumo Corporation
- Flowonix Medical Inc
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Advanced Drug Delivery Systems Market, By Type
- Advanced Drug Delivery Systems Market, By Application
- Advanced Drug Delivery Systems Market, By Carrier Type
- Advanced Drug Delivery Systems Market, By End User
- Advanced Drug Delivery Systems Market, By Region
3. Market Dynamics, Regulations, And Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Epidemiology
4. Advanced Drug Delivery Systems Market, By Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Injection-Based Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Inhalation/Pulmonary Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Transdermal Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Carrier Based Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Transmucosal Drug Delivery System, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Advanced Drug Delivery Systems Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Urology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Inflammatory Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Infectious Diseases, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Advanced Drug Delivery Systems Market, By Carrier Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nanoparticles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Microspheres
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Advanced Drug Delivery Systems Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Research Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Advanced Drug Delivery Systems Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Baxter
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 3M
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Datwyler Holding Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Evonik
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Astrazeneca
- Novo Nordisk A/S
- Corium Innovations, Inc.
- PolyActiva
- Teleflex Incorporated
- Elixir Medical
- Braun SE
- Nemera
- Epion Therapeutics, Inc.
- Terumo Corporation
- Flowonix Medical Inc
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
